Back to the articles
We had new publications this summer!
We are pleased to report the recent publication of the results from a clinical trial conducted with our partner Biostime in the journal Beneficial Microbes. The study was aimed at assessing the safety and the effects of a probiotic supplement (Bifidobacterium infantis R0033, Bifidobacterium bifidum R0071, and Lactobacillus helveticus R0052) on mucosal immune competence and digestive function in healthy formula-fed infants. Our results show that formula-fed infants receiving probiotics maintained higher faecal secretory Immunoglobulin A (sIgA) levels at the end of the four-week treatment period, suggesting a positive effect of probiotics on intestinal sIgA production. This study demonstrates once more the safety of this probiotic formulation in infants. Formula-fed infants may benefit from probiotics supplementation to sustain the development of the GI tract mucosal immunity. Read the study here!
More good news! The results of a collaboration with Dr Stan Kubow’s team at McGill University have just been published in Nutrients. The in vitro study entitled “Probiotic Supplementation is Associated with Increased Antioxidant Capacity and Copper Chelation in C. difficile-Infected Fecal Water” supports the notion that probiotic strains with higher reducing and copper chelation abilities could provide an effective strategy to combat the enterotoxin-mediated intestinal toxicity associated with increased free radical production in C. difficile infections. Read the study here!